Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Abemaciclib + Hormone Therapy for Breast Cancer
Recruiting1 awardPhase 3
Brewer, Maine
This trial is testing abemaciclib as a treatment for early breast cancer in people who are also taking hormone therapy. It will last up to 10 years.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.